Annual report
4360.TEDINET S100R3ZN
Period2022-04-01 → 2023-03-31
Filed2023-06-30
StandardJapan GAAP
ConsolidatedYes
Data checks22 of 22 passed
Key figures · 72
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥11.9bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥10.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | ¥991m | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥740m | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥1.2bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥881m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥1.1bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥940m | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥821m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥712m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥821m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥712m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥15.0bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥13.6bn | at 2022-03-31 | Cons. | Assets |
| Total liabilities | ¥4.0bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥3.3bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥11.0bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥10.3bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥9.8bn | at 2021-03-31d | Cons. | Net assets |
| Cash and deposits | ¥3.7bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.0bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.7bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.0bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥714m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥199m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥422m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥125m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥200m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥103.26 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥90.52 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥1,384.71 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,300.81 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 73.5% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.8% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 7.7% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.9% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| Employees | 236 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 241 | at 2022-03-31 | Cons. | Number of employees |
| Revenue | ¥672m | 2022-04-01 → 2023-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥317m | 2021-04-01 → 2022-03-31 | Standalone | Operating revenue1 |
| Operating income | ¥375m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥173m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥760m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥188m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Profit before tax | ¥814m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥242m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥662m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥174m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Total assets | ¥11.2bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥10.6bn | at 2022-03-31 | Standalone | Assets |
| Total liabilities | ¥165m | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥79m | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥11.1bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥10.5bn | at 2022-03-31 | Standalone | Net assets |
| Cash and deposits | ¥1.5bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥700m | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥83.29 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.05 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥15 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥7.5 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,388.88 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,324.77 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 98.5% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 99.2% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 6.1% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.7% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 8,625,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,625,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Employees | 8 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 7 | at 2022-03-31 | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 60
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥91m |
| Reconciling Itemsreconciling | depreciation | 2022-04-01 → 2023-03-31 | ¥117m |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥6.1bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | −¥1.1bn |
| Fine Chemical Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥62m |
| Fine Chemical Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥218m |
| Fine Chemical Businessreportable segment | employees | at 2023-03-31 | 96 pure |
| Fine Chemical Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥4.3bn |
| Fine Chemical Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥4.3bn |
| Fine Chemical Businessreportable segment | segment assets | at 2023-03-31 | ¥4.9bn |
| Fine Chemical Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥768m |
| Flame Retardants Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥101m |
| Flame Retardants Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥120m |
| Flame Retardants Businessreportable segment | employees | at 2023-03-31 | 47 pure |
| Flame Retardants Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥6.2bn |
| Flame Retardants Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥6.2bn |
| Flame Retardants Businessreportable segment | segment assets | at 2023-03-31 | ¥3.1bn |
| Flame Retardants Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥1.3bn |
| Health Support Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥31m |
| Health Support Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥31m |
| Health Support Businessreportable segment | employees | at 2023-03-31 | 14 pure |
| Health Support Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥1.3bn |
| Health Support Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥1.3bn |
| Health Support Businessreportable segment | segment assets | at 2023-03-31 | ¥845m |
| Health Support Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥31m |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥195m |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥369m |
| —segment total | employees | at 2023-03-31 | 157 pure |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥11.9bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥11.9bn |
| —segment total | segment assets | at 2023-03-31 | ¥8.9bn |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | ¥2.1bn |
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥70m |
| Reconciling Itemsreconciling | depreciation | 2021-04-01 → 2022-03-31 | ¥107m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥4.9bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥1.0bn |
| Fine Chemical Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥316m |
| Fine Chemical Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥200m |
| Fine Chemical Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥4.5bn |
| Fine Chemical Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥4.5bn |
| Fine Chemical Businessreportable segment | segment assets | at 2022-03-31 | ¥5.0bn |
| Fine Chemical Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥637m |
| Flame Retardants Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥196m |
| Flame Retardants Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥113m |
| Flame Retardants Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥5.0bn |
| Flame Retardants Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥5.0bn |
| Flame Retardants Businessreportable segment | segment assets | at 2022-03-31 | ¥2.9bn |
| Flame Retardants Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥993m |
| Health Support Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥80m |
| Health Support Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥29m |
| Health Support Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥1.2bn |
| Health Support Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥1.2bn |
| Health Support Businessreportable segment | segment assets | at 2022-03-31 | ¥773m |
| Health Support Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥158m |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥593m |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥343m |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥10.7bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥10.7bn |
| —segment total | segment assets | at 2022-03-31 | ¥8.6bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥1.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,263
| Item | Context | Value | Unit |
|---|---|---|---|
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row12Member | - | JPY |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row12Member | 36000000 | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row13Member | - | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row13Member | 2000 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row13Member | - | JPY |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row13Member | 6000000 | JPY |
| Number of issues shares not listed investment shares held for pure investment reporting company | CurrentYearInstant | - | |
| Book value equity securities not listed investment equity securities held for pure investment reporting company | CurrentYearInstant | - | JPY |
| Number of issues shares not listed investment shares held for pure investment reporting company | Prior1YearInstant | - | |
| Book value equity securities not listed investment equity securities held for pure investment reporting company | Prior1YearInstant | - | JPY |
| Number of issues shares other than those not listed investment shares held for pure investment reporting company | CurrentYearInstant | 3 | |
| Book value equity securities other than those not listed investment equity securities held for pure investment reporting company | CurrentYearInstant | 111000000 | JPY |
| Number of issues shares other than those not listed investment shares held for pure investment reporting company | Prior1YearInstant | 3 | |
| Book value equity securities other than those not listed investment equity securities held for pure investment reporting company | Prior1YearInstant | 85000000 | JPY |
| Total of dividends received equity securities not listed investment equity securities held for pure investment reporting company | CurrentYearDuration | - | JPY |
| Total of valuation gain loss equity securities not listed investment equity securities held for pure investment reporting company | CurrentYearDuration | - | JPY |
| Total of gain loss on sale equity securities not listed investment equity securities held for pure investment reporting company | CurrentYearDuration | - | JPY |
| Total of dividends received equity securities other than those not listed investment equity securities held for pure investment reporting company | CurrentYearDuration | 2000000 | JPY |
| Total of gain loss on sale equity securities other than those not listed investment equity securities held for pure investment reporting company | CurrentYearDuration | - | JPY |
| Total of valuation gain loss equity securities other than those not listed investment equity securities held for pure investment reporting company | CurrentYearDuration | 27000000 | JPY |
| Cash and deposits | Prior1YearInstant | 2044000000 | JPY |
| Cash and deposits | CurrentYearInstant | 3721000000 | JPY |
| Accounts receivable trade | Prior1YearInstant | 3684000000 | JPY |
| Accounts receivable trade | CurrentYearInstant | 3032000000 | JPY |
| Electronically recorded monetary claims operating ca | Prior1YearInstant | 304000000 | JPY |
| Electronically recorded monetary claims operating ca | CurrentYearInstant | 452000000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 1098000000 | JPY |
| Merchandise and finished goods | CurrentYearInstant | 1876000000 | JPY |
| Work in process | Prior1YearInstant | 343000000 | JPY |
| Work in process | CurrentYearInstant | 521000000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 576000000 | JPY |
| Raw materials and supplies | CurrentYearInstant | 835000000 | JPY |
| Other ca | Prior1YearInstant | 382000000 | JPY |
| Other ca | CurrentYearInstant | 89000000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -3000000 | JPY |
| Allowance for doubtful accounts ca | CurrentYearInstant | -3000000 | JPY |
| Current assets | Prior1YearInstant | 8432000000 | JPY |
| Current assets | CurrentYearInstant | 10527000000 | JPY |
| Buildings and structures net | Prior1YearInstant | 645000000 | JPY |
| Buildings and structures net | CurrentYearInstant | 585000000 | JPY |
| Machinery equipment and vehicles net | Prior1YearInstant | 1164000000 | JPY |
| Machinery equipment and vehicles net | CurrentYearInstant | 896000000 | JPY |
| Land | Prior1YearInstant | 906000000 | JPY |
| Land | CurrentYearInstant | 711000000 | JPY |
| Construction in progress | Prior1YearInstant | 76000000 | JPY |
| Construction in progress | CurrentYearInstant | 126000000 | JPY |
| Other net ppe | Prior1YearInstant | 170000000 | JPY |
| Other net ppe | CurrentYearInstant | 168000000 | JPY |
| Property plant and equipment | Prior1YearInstant | 2963000000 | JPY |
| Property plant and equipment | CurrentYearInstant | 2488000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 22 of 22 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |